Otis Worldwide

OTIS · NYSE

$72.07+$1.03 (+1.45%)TodayMarket closed · Oct 20, 4:05 PM ET

Prev close $71.04

OTIS analyst rating

HoldConsensus of 7 analysts over the last 12 months. 43% rate it a buy.

Strong buy0
Buy3
Hold2
Underperform2
Sell0

12-month price target · 16 analysts

Average $86.91 (+20.6% upside)

Low: $73.73
Now: $72.07
High: $107.64

Upgrades and downgrades

The latest rating actions, newest first

OTIS analyst upgrades, downgrades and rating actions
Firm	Date	Action	Rating	Price target	Hit rate
Wells Fargo	Sep 25, 2026	Initiates	Underweight	$77.00	60%
Bernstein	Jul 23, 2026	Maintains	Outperform	$97.00 → $90.00	25%
Evercore ISI Group	Jul 23, 2026	Maintains	Outperform	$100.00 → $95.00	35%
RBC Capital	Apr 23, 2026	Maintains	Outperform	$110.00 → $105.00	0%
Barclays	Apr 23, 2026	Maintains	Underweight	$80.00 → $77.00	65%
Evercore ISI Group	Apr 13, 2026	Initiates	Outperform	$100.00	35%
Wolfe Research	Apr 8, 2026	Downgrade	Outperform → Peer Perform	—	59%
Barclays	Apr 1, 2026	Maintains	Underweight	$90.00 → $80.00	65%
Wells Fargo	Apr 1, 2026	Maintains	Equal-Weight	$92.00 → $80.00	51%
JP Morgan	Jan 16, 2026	Maintains	Overweight	$111.00 → $116.00	60%

The case for and against

Updated Jan 12, 2026

Bull case

Otis Worldwide has demonstrated a robust positive trajectory, with a 22% year-over-year increase in mod order intake and a backlog up 16% year-over-year as of Q2, indicating strong demand and operational momentum. Management anticipates further acceleration in the latter half of the year, with the backlog showing an 8% increase by the end of the quarter. Additionally, the company has consistently increased its new equipment market share since 2020, achieved a doubling in the growth rate of its service portfolio units, and outperformed key competitors in margin expansion, all contributing to a favorable outlook for the stock.

Bear case

Otis Worldwide has experienced a significant negative shift in its financial outlook, marked by a reduction in guidance for the fourth consecutive quarter, leading to a notable 13% sell-off of its stock. The company's Q2 results showed a decline in organic sales by 2%, indicating potential challenges in revenue generation. Additionally, the updated guidance for 2025 reflects decreased organic sales expectations across three out of five categories, highlighting broader operational and market-related difficulties.

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.